Paolo Tarantino: Trastuzumab deruxtecan is now FDA approved for ANY treatment-refractory HER2+ solid tumor

Vivek Subbiah: First ADC tissue agnostic drug approved!

FDA granted accelerated approval to ponatinib with chemotherapy for adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Patrick Hwu: The FDA approved a groundbreaking treatment called TIL Therapy for advanced melanoma

Laurie Glimcher: Belzutifan is approved by the FDA

FDA approved enfortumab vedotin-ejfv with pembrolizumab for patients with locally advanced or metastatic urothelial cancer